Cannara Biotech Inc (LOVE.V)
0.81
+0.01
(+1.25%)
CAD |
TSXV |
May 17, 16:00
Cannara Biotech Cash from Financing (TTM): -1.102M for Feb. 29, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| February 29, 2024 | -1.102M |
| November 30, 2023 | -1.743M |
| August 31, 2023 | -3.719M |
| May 31, 2023 | 13.49M |
| February 28, 2023 | 13.73M |
| November 30, 2022 | 14.73M |
| August 31, 2022 | 25.46M |
| May 31, 2022 | 39.56M |
| February 28, 2022 | 39.23M |
| November 30, 2021 | 42.14M |
| Date | Value |
|---|---|
| August 31, 2021 | 33.25M |
| May 31, 2021 | 2.699M |
| February 28, 2021 | 2.615M |
| November 30, 2020 | 0.106M |
| August 31, 2020 | -0.9148M |
| May 31, 2020 | 1.046M |
| February 29, 2020 | 6.402M |
| November 30, 2019 | 42.94M |
| August 31, 2019 | 42.66M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-3.719M
Minimum
Aug 2023
42.94M
Maximum
Nov 2019
16.45M
Average
13.49M
Median
May 2023